Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 8.231.623.86-41.80-15.63

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 8.23 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar20268.23
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2026 8.23
408.02
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹200.1 Cr 3.3% 10.9% -43.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

3.3%

10.9%

-43.8%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses